The end of the Wednesday session will be crucial, as the markets will learn what the tariffs will be like around the world. At this point, caution will be paramount, as we just don’t know much about where we can go.

Momentum factors and sector rotation analysis suggest that further potential downside prevails in the Nasdaq 100 despite a “cheaper” valuation. Click to read.

Vertex Pharmaceuticals (VRTX) is the second stock to buy for the Nasdaq 100 correction. The biotech stock offers stability and growth, making it a savvy pick to weather tech-heavy turbulence.

The Nasdaq 100 (NDX) is up today as the index shrugs off concerns about the economy and President Donald Trump’s trade war. These worries have

Lululemon Athletica (NASDAQ:LULU) is driving the Nasdaq-100 (NDX) into a sharp decline, with shares plunging 12.7% on Friday. The tech-heavy index is down 2% as traders contend with President Trump's increasing trade war concerns and renewed inflation concerns,

US indices retreat on tariff worries as VIX jumps to 22.44. Nvidia drops 3.9%, Microsoft falls 2.2%, while defensive sectors provide limited market support.

The tech-heavy Nasdaq-100 index is down by more than 10% from the all-time high it set last month, but it was down by as much as 13% earlier in March. A broad sell-off swept the U.S. stock market as historically high valuations ran up against rising fears and uncertainties about tariffs,

with Meta the last stock to turn negative YTD. Looking at the tech-heavy Nasdaq 100 (NDX) (QQQ), Societe Generale notes that the recent selloff has wiped out nearly all of the AI valuation premium in given to stocks in the index. Valuation premium is the ...